India gives Hetero Labs approval to make Gilead's Covid-19 drug
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard

Thursday
June 30, 2022

Sign In
Subscribe
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
THURSDAY, JUNE 30, 2022
India gives Hetero Labs approval to make Gilead's Covid-19 drug

Coronavirus chronicle

Reuters
21 June, 2020, 05:35 pm
Last modified: 21 June, 2020, 05:55 pm

Related News

  • India hikes taxes on kitchenware, farm machinery
  • G7 discussions with China, India on Russian oil price cap positive -source
  • Pakistan links emerge from savage Hindu slain
  • Police in northwest India ban public gatherings, suspend internet after Hindu slain
  • Indian man beheaded for supporting Nupur Sharma, 2 held

India gives Hetero Labs approval to make Gilead's Covid-19 drug

The drug, which will be marketed under the brand name Covifor, will likely be priced at 5,000 to 6,000 rupees ($66-$79) for a 100 milligram dose, Hetero said

Reuters
21 June, 2020, 05:35 pm
Last modified: 21 June, 2020, 05:55 pm
File Photo: Small bottles labeled with a "Vaccine Covid-19" sticker and a medical syringe are seen in this illustration taken April 10, 2020. Reuters/Dado Ruvic/Illustration/File Photo
File Photo: Small bottles labeled with a "Vaccine Covid-19" sticker and a medical syringe are seen in this illustration taken April 10, 2020. Reuters/Dado Ruvic/Illustration/File Photo

India's drug regulator has given Hetero Labs the green light to manufacture and market its generic version of Gilead Science's experimental COVID-19 treatment remdesivir, the Indian pharmaceutical company said on Sunday.

The drug, which will be marketed under the brand name Covifor, will likely be priced at 5,000 to 6,000 rupees ($66-$79) for a 100 milligram dose, Hetero said.

India's Cipla Ltd has also received approval from the Drug Controller General of India (DGCI) to manufacture and market the drug, according to a report in Indian Express.

Cipla and DGCI were not immediately available for comment.

Gilead Sciences Inc signed non-exclusive licensing pacts last month with five generic drugmakers based in India and Pakistan to expand the supply of its COVID-19 treatment.

The pacts allow Jubilant Life Sciences Ltd, Cipla, Hetero Labs, Mylan NV and Ferozsons Laboratories Ltd to make and sell the drug in 127 countries. 

Top News

India / Coronavirus Vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Representational image
    Some amnesty for offshore assets kept, corporate taxes cut
  • RnB artist R Kelly. Photo: Getty Images via BBC
    US Artist R Kelly sentenced to 30 years on sexual abuse charges
  • Saudi Arabia to celebrate Eid-ul-Adha on 9 July
    Saudi Arabia to celebrate Eid-ul-Adha on 9 July

MOST VIEWED

  • Test tubes are seen in front of displayed Pfizer and Biontech logos in this illustration taken, May 21, 2021. Reuters: llustration
    BioNTech, Pfizer to start testing universal vaccine for coronaviruses
  • A woman holds a small bottle labelled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado Ruvic/File Photo
    S Korea approves first domestically developed Covid vaccine
  • Photo: Collected
    US medical experts call for Omicron-specific Covid boosters
  • David E Adler. Sketch: TBS
    Who managed Covid-19 best, and why?
  • People line up at a nucleic acid testing station, following the coronavirus disease (COVID-19) outbreak, in Beijing, China, June 16, 2022. REUTERS/Thomas Peter/File Photo
    China slashes Covid quarantine time for international travellers
  • Covid-19 deaths were reported from Gorakhpur, Jalaun, Bulandshahr, Kannauj, Sonbhadra, Gonda, Bhadohi, Basti, Kushinagar and Mau (HT Photo)
    India sees 45% jump in a day with 17,073 new Covid cases

Related News

  • India hikes taxes on kitchenware, farm machinery
  • G7 discussions with China, India on Russian oil price cap positive -source
  • Pakistan links emerge from savage Hindu slain
  • Police in northwest India ban public gatherings, suspend internet after Hindu slain
  • Indian man beheaded for supporting Nupur Sharma, 2 held

Features

Mahathir accused financial titans of seeking to reverse decades of economic development that propelled tens of millions into the middle class. Photo: Bloomberg

George Soros, Mahathir and the legacy of 1997

11h | Panorama
 If Bangladesh produces and exports high-value-added MMF products right now, we can increase our total export by around 25% in value. Photo: Mumit M

Time ripe for Bangladesh RMG sector to focus more on man-made fibres

14h | Panorama
Human Library Bangladesh has organised so far nine sessions; eight have been held in different parts of Dhaka and one in Khulna. Photo: Courtesy

Human Library Bangladesh: Where the halls come alive with human voices

16h | Panorama
Abortion is a part of healthcare. Photo: Bloomberg

Abortion is healthcare and women’s rights are human rights

1d | Panorama

More Videos from TBS

Severodonetsk now under Russian control

Severodonetsk now under Russian control

3h | Videos
South African boy drove ambition, says Elon's father

South African boy drove ambition, says Elon's father

3h | Videos
Why Dollar crisis will last long?

Why Dollar crisis will last long?

4h | Videos
Beautiful mural at Padma bridge

Beautiful mural at Padma bridge

8h | Videos

Most Read

1
Padma Bridge from satellite. Photo: Screengrab
Bangladesh

Padma Bridge from satellite 

2
Meet the man behind 'Azke amar mon balo nei'
Splash

Meet the man behind 'Azke amar mon balo nei'

3
Photo: TBS
Bangladesh

Motorcycles banned on Padma Bridge 

4
Photo: Courtesy
Corporates

Gree AC being used in all parts of Padma Bridge project

5
Photo: Collected
Economy

Tech startup ShopUp bags $65m in Series B4 funding

6
World Bank to give Bangladesh $18b IDA loans in next five years
Economy

World Bank to give Bangladesh $18b IDA loans in next five years

EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2022
The Business Standard All rights reserved
Technical Partner: RSI Lab
BENEATH THE SURFACE
An aerial view of a MRT Line-6 construction site. Work on the first elevated metro rail of Bangladesh is going on in full swing. A total of 16 elevated stations will connect the capital’s Uttara to Motijheel via Mirpur, Farmgate and Dhaka University. The photo was taken from Farmgate area recently. Photo: Rajib Dhar

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net